BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34403195)

  • 21. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
    Hou Y; Li H; Huo W
    Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An RNA-dependent and phase-separated active subnuclear compartment safeguards repressive chromatin domains.
    Lerra L; Panatta M; Bär D; Zanini I; Tan JY; Pisano A; Mungo C; Baroux C; Panse VG; Marques AC; Santoro R
    Mol Cell; 2024 May; 84(9):1667-1683.e10. PubMed ID: 38599210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
    Guzel E; Karatas OF; Duz MB; Solak M; Ittmann M; Ozen M
    Prostate; 2014 Nov; 74(15):1498-505. PubMed ID: 25175483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into prostate cancer stem cells.
    Chen X; Rycaj K; Liu X; Tang DG
    Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review.
    Czerwinska P; Mackiewicz AA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.
    Palomera-Sanchez Z; Watson GW; Wong CP; Beaver LM; Williams DE; Dashwood RH; Ho E
    J Nutr Biochem; 2017 Sep; 47():113-119. PubMed ID: 28582660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
    Queisser A; Hagedorn S; Wang H; Schaefer T; Konantz M; Alavi S; Deng M; Vogel W; von Mässenhausen A; Kristiansen G; Duensing S; Kirfel J; Lengerke C; Perner S
    Oncogene; 2017 Mar; 36(11):1573-1584. PubMed ID: 27617580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
    Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
    Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of microRNA‑574 in cancer stem cells causes recurrence of prostate cancer via targeting REL.
    Lai X; Guo Y; Guo Z; Liu R; Wang X; Wang F
    Oncol Rep; 2016 Dec; 36(6):3651-3656. PubMed ID: 27779701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
    Yadav S; Kowolik CM; Lin M; Zuro D; Hui SK; Riggs AD; Horne DA
    Mol Carcinog; 2019 Jan; 58(1):113-125. PubMed ID: 30242889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.
    Hernández-Llodrà S; Segalés L; Juanpere N; Marta Lorenzo T; Salido M; Nonell L; David López T; Rodríguez-Vida A; Bellmunt J; Fumadó L; Cecchini L; Lloreta-Trull J
    Prostate; 2021 Dec; 81(16):1267-1277. PubMed ID: 34533858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
    Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
    J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer.
    Sui X; Cai J; Li H; He C; Zhou C; Dong Y; Chen L; Zhang B; Wang Y; Zhang Y; Qiu Y; Zhang Y; Zhao Y; Huang Y; Shen Y; Wu H; Xiao J; Mason C; Zhu Q; Han S
    Cell Death Dis; 2018 May; 9(5):523. PubMed ID: 29743605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.
    Chen P; Chaikuad A; Bamborough P; Bantscheff M; Bountra C; Chung CW; Fedorov O; Grandi P; Jung D; Lesniak R; Lindon M; Müller S; Philpott M; Prinjha R; Rogers C; Selenski C; Tallant C; Werner T; Willson TM; Knapp S; Drewry DH
    J Med Chem; 2016 Feb; 59(4):1410-24. PubMed ID: 25799074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
    Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
    J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
    Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing.
    Dalle Vedove A; Cazzanelli G; Batiste L; Marchand JR; Spiliotopoulos D; Corsi J; D'Agostino VG; Caflisch A; Lolli G
    ACS Med Chem Lett; 2022 Sep; 13(9):1434-1443. PubMed ID: 36105334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.